Actively Recruiting

Phase Not Applicable
Age: 18Years - 40Years
All Genders
Healthy Volunteers
NCT04743271

Food and Circadian Timing

Led by Oregon Health and Science University · Updated on 2025-11-10

14

Participants Needed

1

Research Sites

208 weeks

Total Duration

On this page

Sponsors

O

Oregon Health and Science University

Lead Sponsor

N

National Institutes of Health (NIH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goals of this study are to uncover the influence of diet on the human circadian timing system. The protocol is a 46-day (28 outpatient days, 18 inpatient days over two 9 day visits) randomized cross-over study designed to elucidate the speed of entrainment in response to a high-fat diet.

CONDITIONS

Official Title

Food and Circadian Timing

Who Can Participate

Age: 18Years - 40Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Healthy, lean men and women
  • Between 18 and 40 years of age
Not Eligible

You will not qualify if you...

  • Major dietary restrictions such as entirely dairy-free or meat-free diets
  • Body mass index (BMI) not between 18.5 and 24.9 kg/m2 or waist circumference exceeding 94 cm for men or 80 cm for women
  • Psychiatric or psychological conditions unsuitable for participation
  • Current use of drugs, alcohol, or smoking
  • Use of prescribed or over-the-counter medications
  • History of irregular day/night work, regular night work, or rotating shifts in the past year
  • Travel across more than one time zone in the past three months
  • Habitual consumption of a high-fat diet
  • Chronobiologic or sleep disorders
  • Cardiovascular diseases
  • Metabolic syndrome, including any two of: low HDL cholesterol, high blood pressure, elevated fasting blood glucose, or high triglycerides
  • Pre-diabetes or diabetes
  • Hypertension
  • Respiratory system disorders
  • Kidney and urinary tract disorders
  • Infectious diseases
  • Gastrointestinal system disorders
  • Immune system disorders
  • Hematopoietic system disorders
  • Neoplastic diseases
  • Endocrine and metabolic diseases
  • Neurologic disorders
  • Current participation in another research study that affects safe participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Oregon Health & Science University

Portland, Oregon, United States, 97239

Actively Recruiting

Loading map...

Research Team

A

Andrew McHill, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here